Kotai Bio

Minoh, JP · 1 known investors

KOTAI Biotechnologies develops an immune AI platform and big data analysis pipeline that combines artificial intelligence with immunology for antibody and immune-repertoire analysis. The company serves pharmaceutical and life-science research applications such as antibody modeling, single-cell analysis, and cancer and infectious-disease immunology research.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtech